Publication | Closed Access

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

Hematological MalignancyTransplantationMarrow TransplantationMedicineStem Cell TransplantationHematologyMyeloid NeoplasiaSorafenib MaintenanceRadiation OncologyOncologyCell TransplantationPhase 3Health Sciences